Journal profile · Obstetrics & Gynecology
Breast Care
ISSN 1661-3791 · eISSN 1661-3805 · S. Karger AG · GERMANY · Bimonthly · Founded 2006
Breast Care: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.22; hybrid open access; APC charged, amount not published; median 125 days to acceptance (84 articles, last 24 months); community-reported acceptance: easy; 75 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Breast Care is published by S. Karger AG and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Breast Lesions and Carcinomas and Human auditory perception and evaluation, together about 36.4% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Breast Care is a scientific journal that encompasses all aspects of breast biology. As an interdisciplinary journal, it includes manuscripts describing research, prevention, diagnosis, and treatment of malignant and benign diseases of the breast. In addition to presenting current developments in clinical research, it addresses broader topics in clinical practice by including articles that address legal, financial, and economic issues of importance. Breast Care is addressed to clinicians and practitioners working and researching in the field of breast health, breast ailments, and breast cancer.
From the journal's Aims & Scope
Research area (LetPub): Obstetrics & Gynecology
Editor-in-chief Nina DitschPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology18%
- Breast Lesions and CarcinomasMedicine9.5%
- Human auditory perception and evaluationEngineering8.9%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance7.7%
- HER2/EGFR in Cancer ResearchMedicine6.4%
- Breast Implant and ReconstructionMedicine5.7%
- Advanced Breast Cancer TherapiesMedicine5.4%
- Cancer Treatment and PharmacologyMedicine5.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Obstetrics & Gynecology | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Obstetrics & Gynecology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Obstetrics & Gynecology | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.22LetPub ·
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 4.2LetPub ·
- CiteScore (publisher)
- 4.2Publisher website ·
- SJR 2026-06
- 0.68LetPub ·
- SNIP 2026-06
- 0.8LetPub ·
- h-index
- 25LetPub ·
- h-index
- 64OpenAlex ·
- i10-index
- 553OpenAlex ·
- 2-year mean citedness
- 1.32OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 21.17%LetPub ·
Volume
- Articles per year
- 64LetPub ·
Articles by year OpenAlex count · 2,137 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 32 | 30 | 7 |
| 2025 | 75 | 62 | 87 |
| 2024 | 39 | 27 | 98 |
| 2023 | 72 | 60 | 387 |
| 2022 | 67 | 59 | 425 |
| 2021 | 89 | 82 | 910 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
125 daysMedian, submission to acceptance · P25–P75 79 days – 167 days
- Acceptance to online
- median 15 days (84 articles)
- Submission to online
- median 151 days
- Sample
- 84 articles with submission and acceptance dates (97 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 25.5%Publisher website ·
- Submission to final decision
- 49 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- S. Karger AG
- Country or region
- GERMANY
- Language
- Multi-Language
- Frequency
- Bimonthly
- Founded
- 2006
- ISSN
- 1661-3791
- Electronic ISSN
- 1661-3805
- Latest issue on the website
- Volume 21, Issue 3 (June 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Breast Care
What CAS zone is Breast Care in?
In the 2025 upgraded edition of the CAS Journal Ranking, Breast Care is in Zone 4 of Medicine, and in Zone 4 of the minor category Obstetrics & Gynecology / Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Breast Care?
The latest impact factor listed by LetPub is 2.22; CiteScore 4.2, h-index 64.
How long does peer review take at Breast Care?
Based on the dates recorded on 84 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 125 days (interquartile range 79–167 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 25.5%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Breast Care?
According to LetPub and DOAJ records, Breast Care is indexed in SCIE and Scopus.
Is Breast Care open access, and what is the APC?
Breast Care is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .